X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

OmniSYS Acquires Clinical Pharmacy Services Provider STRAND Clinical Technologies

Content Team by Content Team
11th July 2019
in News
OmniSYS Acquires Clinical Pharmacy Services

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

OmniSYS, a technology company focused on innovative solutions for the retail pharmacy industry, announced that it has acquired STRAND Clinical Technologies.

STRAND helps retail pharmacists launch and support clinical services within their community. Their intervention, documentation and education platform supports pharmacies across the country in providing preventative care services and engaging patients with chronic diseases. From clinical billing and education, to creating and sending pharmacist eCare plans, STRAND helps pharmacists grow their business by enabling pharmacies to become health hubs for their communities.

“The pharmacy’s role in care delivery continues to expand. With a growing population of people with age-related and chronic health conditions combined with the desire for convenient and accessible care, community pharmacists are uniquely positioned to provide preventative care and low-acuity services traditionally performed in a doctor’s office,” said John King, OmniSYS chief executive officer. “STRAND shares our passion for leveraging the pharmacy setting to improve patient outcomes. Their state-of-the-art technology is designed to support clinical workflow in the pharmacy both now and in the future.”

STRAND was founded in 2009 with the goal of transforming the community pharmacy marketplace by inspiring and empowering pharmacists to advance their clinical pharmacy practice. Their portfolio includes solutions for clinical documentation, education and training, patient engagement, opioid risk assessment and in-store advertising.

“Recognizing the tremendous potential of community pharmacists as clinical service providers, we built a platform that empowers pharmacies to expand and grow their business,” said David Pope, PharmD, CDE, STRAND co-founder and chief innovation officer. “OmniSYS not only shares this vision, but has the market presence and resources available to ensure that our vision becomes reality.”

About OmniSYS
OmniSYS is a technology company that helps pharmacies and pharmaceutical manufacturers drive growth by engaging patients, competing on value and distinguishing their brands. With over 25 years of experience, we leverage our unique market insight, pharmacy workflow expertise and extensive industry knowledge to deliver valuable solutions to our customers. We provide medical billing, automated pricing, immunization services and patient communication solutions for pharmacies and consumer engagement programs for pharmaceutical manufacturers that drive value and deliver real results. OmniSYS currently serves over 25,000 pharmacies, connects to hundreds of payers and touches millions of patient lives.

Previous Post

Stem Cell Community Day 2019: Bringing the global stem cell research community together on November 21 in Portugal

Next Post

Novartis aims to solve EpiPen shortage with generic launch of Symjepi to US pharmacies

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
Novartis EpiPen

Novartis aims to solve EpiPen shortage with generic launch of Symjepi to US pharmacies

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In